By Topic

Fabrication of novel interactive biomaterials via peptide integration for tissue engineering applications

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

4 Author(s)
Sanghvi, A.B. ; Dept. of Biomed. Eng., Texas Univ., Austin, TX, USA ; Miller, K.P.-H. ; Belcher, Angela M. ; Schmidt, C.E.

New classes of materials are being designed to interact specifically with mammalian cells to control their behavior and subsequently direct the formation of organ specific tissue. One approach is to modify the surface of the material so that it will selectively interact with cells through specific biomolecular recognition events, thus, rendering it "biomimetic". Materials can be functionalized with a large variety of biologically active molecules including: peptides that affect cell attachment, growth factors that promote cell growth, and cellular differentiation. A novel approach to creating biomimetic materials lies in the identification of peptides that bind commercially available polymers with high specificity and affinity. Phage display technology, a combinatorial method of screening peptide sequence library, was used to select peptides that have binding specificity to the polymer-based biomaterials studied.

Published in:

Engineering in Medicine and Biology, 2002. 24th Annual Conference and the Annual Fall Meeting of the Biomedical Engineering Society EMBS/BMES Conference, 2002. Proceedings of the Second Joint  (Volume:3 )

Date of Conference:

23-26 Oct. 2002